← Back to Patent Explorer
US4883668A Expired / Lapsed US ⏱️ 0.0 years remaining

Material for endermic administration pre-treatment

Assignee: Advance KK
•
Filing: 1989-02-15
•
Granted: 1989-11-28
•
Expires: 2009-02-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A material for endermic administration pre-treatment is disclosed wherein the material comprises a support and a substance capable of removing corneum, for example, an adhesive, and the substance is substantially uniformly distributed on the support in the form of small areas discontinuous to each other at a density of 0.001 to 5%. Pre-treatment of the skin by this material enhances the absorption of a medicament in an endermic administration.

Inventors

  • 👤 Midori Ohta

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 03:10
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0014; A61M; A61M35/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 124 words
In inontophoretic transdermal drug administration, the improved method which comprises pre-treating a portion of the skin to which the drug administration is to be made by pressing a substance capable of removing stratum corneum, and which is substantially uniformly distributed on a support in the form of small areas discontinuous to each other at a density of 0.001 to 5%, against a portion of the skin to which the drug administration is to be made, adhering said substance to the stratum corneum on said skin, and removing the substance together with the support from the skin so as to remove a portion of the stratum corneum and provide fine openings in the stratum corneum having reduced impedance and permitting enhanced iontophoretic transdermal drug administration.
Claim 2
Dependent Claim 124 words
In inontophoretic transdermal drug administration, the improved method which comprises pre-treating a portion of the skin to which the drug administration is to be made by pressing a substance capable of removing stratum corneum, and which is substantially uniformly distributed on a support in the form of small areas discontinuous to each other at a density of 0.001 to 5%, against a portion of the skin to which the drug administration is to be made, adhering said substance to the stratum corneum on said skin, and removing the substance together with the support from the skin so as to remove a portion of the stratum corneum and provide fine openings in the stratum corneum having reduced impedance and permitting enhanced iontophoretic transdermal drug administration.
Claim 3
Dependent Claim 21 words
The method according to claim 1, wherein said substance capable of removing stratum corneum is an adhesive substantially non-toxic to skin.
Claim 4
Dependent Claim 14 words
The method according to claim 2, wherein said adhesive is a pressure sensitive adhesive.
Claim 5
Dependent Claim 15 words
The method according to claim 3, wherein said pressure sensitive adhesive is a capsular adhesive.
Claim 6
Dependent Claim 21 words
The method according to claim 3, wherein said pressure sensitive adhesive is a natural adhesive, thermoplastic adhesive or synthetic rubber adhesive.
Claim 7
Dependent Claim 20 words
The method according to claim 1, wherein said small area is a circle having a diameter of about 10-300 μm.
Claim 8
Dependent Claim 20 words
The method according to claim 1, wherein said small area is a strip having a width of about 10-300 μm.
Claim 9
Dependent Claim 13 words
The method according to claim 1 having a density of 0.01 to 5%.
Claim 10
Dependent Claim 13 words
The method according to claim 1, wherein the support is a flexible sheet.
Claim 11
Dependent Claim 13 words
The method according to claim 1, wherein the support is a rigid plate.
Claim 12
Dependent Claim 28 words
The method according to claim 1, wherein the rigid plate has a handle on a surface opposite to a surface carrying the substance capable of removing stratum cornes.

References Cited (Backward Citations)

US3339546A Cited
US3342183A Cited
US4140115A Cited
JPS57123117A Cited
US4592753A Cited
US4510197A Cited
US4588762A Cited
US4699792A Cited
US4714655A Cited
JPH0654284A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-27 1993-05-29 1993-11-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-27 1997-05-29 1997-11-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-27 2001-05-29 2001-11-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag